These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 8847821
1. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid]. Fujita S. Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821 [Abstract] [Full Text] [Related]
2. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing]. Yamane N, Igari J. Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005 [Abstract] [Full Text] [Related]
4. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT. Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726 [Abstract] [Full Text] [Related]
7. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. Fleck R, Dietz A, Hof H. J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369 [Abstract] [Full Text] [Related]
9. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs. Tay ST, Tanty Haryanty T, Ng KP, Rohani MY, Hamimah H. Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448 [Abstract] [Full Text] [Related]
10. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. Pfaller MA, Messer SA, Bolmström A, Odds FC, Rex JH. J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571 [Abstract] [Full Text] [Related]
11. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system]. Carrillo-Muñoz AJ, Quindós G, Gasser I, Tur-Tur C, Ruesga MT, Alonso-Vargas R, Arévalo P, Bornay-Llinares FJ, Santos P, del Valle O. Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673 [Abstract] [Full Text] [Related]
14. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. Biochem Biophys Res Commun; 2006 Aug 25; 347(2):401-5. PubMed ID: 16831406 [Abstract] [Full Text] [Related]
15. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients. Lombardi G, Gramegna G, Cavanna C, Michelone G. Microbiologica; 1990 Jul 25; 13(3):201-6. PubMed ID: 2273982 [Abstract] [Full Text] [Related]
16. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media]. Tapia C, León E, Palavecino E. Rev Med Chil; 2003 Mar 25; 131(3):299-302. PubMed ID: 12790079 [Abstract] [Full Text] [Related]
18. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals. Diagn Microbiol Infect Dis; 2008 Jun 25; 61(2):175-80. PubMed ID: 18304773 [Abstract] [Full Text] [Related]
19. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome. Poon M, Cronin DC, Wormser GP, Bottone EJ. Arch Pathol Lab Med; 1988 Feb 25; 112(2):161-2. PubMed ID: 3276290 [Abstract] [Full Text] [Related]